AnaptysBio Inc (ANAB) — Cash Flow-to-Debt Ratio
AnaptysBio Inc (ANAB) has a Cash Flow-to-Debt Ratio of -0.08x as of March 2026, meaning its operating cash flow of $-25.92 Million could theoretically repay 0% of its total liabilities ($316.94 Million) in one year. Explore AnaptysBio Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AnaptysBio Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for AnaptysBio Inc across 13 annual periods. Also explore total assets of AnaptysBio Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for AnaptysBio Inc (2013–2025)
Year-by-year debt coverage analysis for AnaptysBio Inc. For market capitalisation and broader financial context, see ANAB stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $19.70 Million | $327.19 Million | ▲ +118.4% |
| 2024 | -0.33x | $-135.34 Million | $412.97 Million | ▲ +1.2% |
| 2023 | -0.33x | $-120.80 Million | $364.29 Million | ▼ -56.9% |
| 2022 | -0.21x | $-73.59 Million | $348.28 Million | ▼ -31.9% |
| 2021 | -0.16x | $-45.92 Million | $286.64 Million | ▲ +77.6% |
| 2020 | -0.71x | $-14.16 Million | $19.82 Million | ▲ +69.0% |
| 2019 | -2.30x | $-69.52 Million | $30.19 Million | ▼ -7.4% |
| 2018 | -2.14x | $-48.51 Million | $22.63 Million | ▼ -140.2% |
| 2017 | -0.89x | $-19.44 Million | $21.78 Million | ▼ -126.4% |
| 2016 | -0.39x | $-9.03 Million | $22.91 Million | ▲ +43.2% |
| 2015 | -0.69x | $-9.67 Million | $13.94 Million | ▼ -190.6% |
| 2014 | 0.77x | $14.60 Million | $19.07 Million | ▲ +149.8% |
| 2013 | -1.54x | $-5.80 Million | $3.77 Million | — |